MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC Gesamtverbindlichkeiten 2011-2026 | OXFD
Gesamtverbindlichkeiten Jährlich Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 21.6 M | 18.1 M | 56.6 M | 51 M | 17.2 M | 13.2 M | 12 M | 8.53 M | 4.41 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 56.6 M | 4.41 M | 22.5 M |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
5.32 B | $ 115.48 | 0.82 % | $ 35.1 B |  USA |
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.2 | -0.61 % | $ 175 M |  China |
|
Biodesix
BDSX
|
76.4 M | $ 15.07 | 2.1 % | $ 1.95 B | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 24.84 | -0.84 % | $ 690 M | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 8.4 | 3.7 % | $ 33.5 M | Israel |
 |
BioNano Genomics
BNGO
|
29.2 M | $ 1.2 | 0.84 % | $ 6.53 M | USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 173.89 | -0.58 % | $ 8.62 B | USA |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
3.59 B | $ 62.22 | -0.24 % | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 16.82 | 2.31 % | $ 509 M | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.17 | -0.91 % | $ 4.98 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
Celcuity
CELC
|
366 M | $ 112.63 | -0.27 % | $ 5.27 B | USA |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 198.02 | 0.17 % | $ 22 B | USA |
 |
Guardant Health
GH
|
2.11 B | $ 93.83 | 2.94 % | $ 11.8 B | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 76.1 | 0.53 % | $ 5.14 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 498.34 | 1.81 % | $ 14.4 B | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 259.94 | -1.11 % | $ 26 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 114.19 | 2.49 % | $ 9.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.75 B | $ 569.55 | 0.87 % | $ 45.8 B | USA |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 9.41 | 0.21 % | $ 2.04 B | USA |
 |
Illumina
ILMN
|
2.7 B | $ 127.38 | 0.59 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
23.3 B | $ 173.26 | 0.5 % | $ 29.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
779 M | $ 1.34 | -0.74 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 27.11 | -0.66 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 273.72 | 0.36 % | $ 22.8 B | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.75 | 3.49 % | $ 440 M | USA |
 |
Sotera Health Company
SHC
|
2.66 B | $ 14.96 | 0.61 % | $ 4.25 B | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.0 | 3.23 % | $ 1.02 B | USA |
 |
National Research Corporation
NRC
|
121 M | $ 17.16 | -1.04 % | $ 384 M | USA |